milnacipran pierre fabre medicament
pierre fabre medicament - milnacipran - fibromialgija
tardyferon 80 mg obložene tablete
pierre fabre mÉdicament - železov(ii) sulfat - filmsko obložena tableta - železov(ii) sulfat 80 mg / 1 tableta - železov(ii) sulfat
omacor 1000 mg mehke kapsule
pronova biopharma - omega-3-kislinski etilestri 90 - kapsula, mehka - omega-3-kislinski etilestri 90 1000 mg / 1 kapsula - omega-3-trigliceridi z drugimi estri in kislinami
omacor 1000 mg mehke kapsule
pronova biopharma - omega-3-kislinski etilestri 90 - kapsula, mehka - omega-3-kislinski etilestri 90 1000 mg / 1 kapsula - omega-3-trigliceridi z drugimi estri in kislinami
tantum verde z okusom limone 3 mg pastile
angelini pharma Ősterreich gmbh - benzidamin - pastila - benzidamin 2,68 mg / 1 pastila - benzidamin
tantum verde z okusom mentola 3 mg pastile
angelini pharma Ősterreich gmbh - benzidamin - pastila - benzidamin 2,68 mg / 1 pastila - benzidamin
impulsor
pierre fabre medicament - milnacipran - fibromialgija
braftovi
pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - antineoplastična sredstva - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy.
mektovi
pierre fabre medicament - binimetinib - melanoma - antineoplastična sredstva - binimetinib v kombinaciji z encorafenib je indiciran za zdravljenje odraslih bolnikov z unresectable ali metastatskega melanoma z braf v600 mutacija.
nerlynx
pierre fabre medicament - neratinib - neoplazme dojke - antineoplastična sredstva - nerlynx je označen za podaljšano adjuvant zdravljenje odraslih bolnikov z zgodnji fazi hormon receptor her2 pozitiven-overexpressed/dopolniti rak dojke, ki so manj kot eno leto od zaključka pred adjuvant trastuzumab, ki temelji terapija.